抗生素概论和合理应用修改.ppt

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
THANK YOU SUCCESS * * 可编辑 * * 此张主要说明社区获得性呼吸道感染主要疾病组成,最常见且较严重的为CAP与AECOPD。 * * 此张主要强调呼吸道感染的趋势-趋向于多种致病菌的混合感染,故临床需要能全面覆盖呼吸道感染致病菌的抗菌药物。 * 要点: 见幻灯。 * 要点: 见幻灯。 * 要点: 老年CAP的特殊危险因素:吸入因素。在老年CAP的抗生素治疗中,要考虑到吸入因素所致厌氧菌感染的情况。 * * * * * 要点: HAP患者的起病时间与肺炎的病原谱和耐药性有密切关系。 * 要点: 病原学特点:不同国家,不同地区,不同医院HAP病原谱经常存在差异。一般认为:早发性HAP致病菌主要为社区获得性病原体;迟发性HAP的致病菌主要考虑耐药致病菌;大多数HAP,特别是VAP,常由多种致病菌引起;无论早发或迟发性VAP,如合并有危险诱发因素则其病原菌分布应同迟发HAP,同时尚要兼顾军团菌感染。 * * * 头孢克洛、头孢丙烯及头孢曲松对PRSP的耐药率为88.2%,88%和23.5% * * * C. difficile was first described in 1935 by Hall and O’Toole. [Ref. 1 Kelly, p. 375] Although the organism released potent toxins, because it was found in the stool of healthy neonates, it was classified as a commensal and passed into obscurity.[Ref. 1 Kelly, p. 375] Pseudomembranous colitis was first described over a century ago, before the discovery of antibiotics.[Ref. 2: Prendergast, p. 768 Ref. 3: Finney, p53] In the 1960s and 1970s, antibiotic-associated pseudomembranous colitis became a major clinical problem.[Ref. 1 Kelly, p. 376; Ref. 4: Kelly, p. 257; Ref. 5: Settle, p. 1217] Initial outbreaks were traced to the use of clindamycin, cephalosporins, and ampicillin. [Ref. 1 Kelly, p. 376; Ref. 6: deLalla, p. 624; Ref. 7: Privitera, p. 208] Reference Kelly CP and JT LaMont. Annu Rev Med. 1998;49:375-390. 2. Prendergast TM, et al. Surgery. 1994;116:768-775. 3. Finny JMT, et al. Bull Johns Hopkins Hosp. 1893;4:53-55. 4. Kelly CP, et al. N Engl J Med. 1994;330:257-262. 5. Settle CD, et al. Aliment Pharmacol Ther. 1998;12:1217-1233. 6. deLalla F, et al, J Antimicrob Chemother. 1989;23:623-631. 7. Privitera G, et al. Antimicrob Agents Chemother. 1991;35:208-210. * Multidrug-resistant pseudomonal strains are very difficult to treat. Trouillet et al. found that prior use of a fluoroquinolone was an independent risk factor for mortality in VAP, and that prior exposure to fluoroquinolones was significantly associated with resistance to imipenem (p=0.05) and ciprofloxacin (p=0.001). This suggests that

文档评论(0)

iuad + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档